![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
JA Bauer and HL Fung
Department of Pharmaceutics, School of Pharmacy, State University of New York, Buffalo.
S-nitrosothiols are potent in vitro vasodilators, but little is known about their in vivo action. In this study, we compared the effects of S- nitroso N-acetyl penicillamine (SNAP) and nitroglycerin (NTG) on left ventricular (LV) hemodynamics in congestive heart failure rats. By using a twoday crossover design, stepwise i.v. infusions of SNAP or NTG at 3, 5 and 8 micrograms/min were administered for 30 min each, followed by a dose of 10 micrograms/min over the next 10 h. LV end- diastolic and peak-systolic pressures (LVEDP and LVPSP, respectively) were measured at selected intervals. SNAP and NTG produced maximal LVEDP reductions of 46 and 44%, respectively, at the highest infusion rate. However, at the lower doses, greater reductions of LVEDP were seen with SNAP. NTG had a smaller effect on LVPSP (maximum 6% reduction) than SNAP (maximum reduction of 15%). During the 10-h infusion of NTG, LVEDP gradually returned to base-line values, indicating the development of tolerance, despite relatively constant plasma levels of NTG over the infusion period. Tolerance in LVEDP effects was not observed during the 10-h infusion of SNAP. In the presence of NTG tolerance, rats were still responsive to SNAP (mean reduction of LVEDP 24%), suggesting the absence of cross-tolerance between these two nitrovasodilators. These results suggest that SNAP is a more potent in vivo vasodilator than NTG, has more arterial action than NTG and is less prone to produce LV hemodynamic tolerance.
This article has been cited by other articles:
|
|
 |
|
  N. Sayed, D. D. Kim, X. Fioramonti, T. Iwahashi, W. N. Duran, and A. Beuve Nitroglycerin-Induced S-nitrosylation and Desensitization of Soluble Guanylyl Cyclase Contribute to Nitrate Tolerance Circ. Res., September 12, 2008; 103(6): 606 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Katsumi, M. Nishikawa, F. Yamashita, and M. Hashida Development of Polyethylene Glycol-Conjugated Poly-S-Nitrosated Serum Albumin, a Novel S-Nitrosothiol for Prolonged Delivery of Nitric Oxide in the Blood Circulation in Vivo J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1117 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shiono, V. Rao, R. D. Weisel, M. Kawasaki, R.-K. Li, D. A. G. Mickle, P. W. M. Fedak, L. C. Tumiati, L. Ko, and S. Verma L-Arginine protects human heart cells from low-volume anoxia and reoxygenation Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H805 - H815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Mihm, C. M. Coyle, B. L. Schanbacher, D. M. Weinstein, and J. A. Bauer Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure Cardiovasc Res, March 1, 2001; 49(4): 798 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Sage, I. S. de la Lande, I. Stafford, C. L. Bennett, G. Phillipov, J. Stubberfield, and J. D. Horowitz Nitroglycerin Tolerance in Human Vessels : Evidence for Impaired Nitroglycerin Bioconversion Circulation, December 5, 2000; 102(23): 2810 - 2815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bauer, T. Nolan, and H.-L. Fung Vascular and Hemodynamic Differences between Organic Nitrates and Nitrites J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 326 - 331. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
